JTCS Medtronic Endurant
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Author home page(s):
Christian P. Brizard
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Stocker, C. F.
Right arrow Articles by Penny, D. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Stocker, C. F.
Right arrow Articles by Penny, D. J.
Related Collections
Right arrow Molecular biology

J Thorac Cardiovasc Surg 2004;127:1523-1525
© 2004 The American Association for Thoracic Surgery


Brief communication

Cardiopulmonary bypass elicits a prominent innate immune response in children with congenital heart disease

Christian F. Stocker, MDa, Lara S. Shekerdemian, MRCP, FRACP, MDa, Kumar Visvanathan, MB BS, FRACP, PhDb,c, Narelle Skinner, Bscb, Christian P. Brizard, MDd, John B. Carlin, BSc, PhD, Astate,f, Steven B. Horton, BAppSc, CCP (Aus), CCP (USA)g, Daniel J. Penny, MD, FRCPIh,*

a Department of Intensive Care, Royal Children's Hospital, Parkville, Victoria, Australia
d Department of Cardiac Surgery, Royal Children's Hospital, Parkville, Victoria, Australia
g Department of Perfusion, Royal Children's Hospital, Parkville, Victoria, Australia
h Department of Cardiology, Royal Children's Hospital, Parkville, Victoria, Australia
b Staph and Strep Group Murdoch Children's Research Institute, Parkville, Victoria, Australia
e Epidemiology and Biostatistics Unit, Murdoch Children's Research Institute, Parkville, Victoria, Australia
c Department of Medicine, Royal Melbourne Hospital, Parkville, Victoria, Australia
f Department of Pediatrics, University of Melbourne, Parkville, Victoria, Australia

Received for publication October 29, 2003; revisions received November 18, 2003; accepted for publication November 24, 2003.

* Address for reprints: Daniel J. Penny, MD, FRCPI, Department of Cardiology, Royal Children's Hospital, Flemington Rd, Parkville, Victoria 3052 Australia
dan.penny{at}rch.org.au

Systemic inflammatory response syndrome (SIRS) is common after operations for congenital heart disease (CHD).1 SIRS is characterized by release of proinflammatory cytokines, but the mechanisms initiating this cascade remain ill defined. Recent data from septic patients and a single study in adults undergoing heart surgery suggest that activation of the innate immune response might provide this early trigger.2,3 However, there are no other data that explore the contribution of the innate immune response in SIRS associated with cardiopulmonary bypass (CPB), specifically none in children. We have investigated, for the first time, the regulation of toll-like receptor 2 (TLR-2) and TLR-4 expression on peripheral blood monocytes of children with an inflammatory response after operations for CHD.

Methods

Nine children (median age, 6 months; weight, 5.6 kg) undergoing surgical intervention for CHD were studied. They were the first cohort to be recruited for a prospective study of moderate hypothermic versus normothermic CPB, which was approved by our institutional ethics committee. Blood samples were taken for TLR-2 and TLR-4 and the cytokines tumor necrosis factor {alpha} (TNF-{alpha}) and interleukin 6 (IL-6) at the following time points: before CPB (after anesthesia), after crossclamp removal, and at 4, 24, and 48 hours after separation from CPB. All children received methylprednisolone (25 mg/kg) after induction of anesthesia and underwent hemofiltration during bypass and modified ultrafiltration after separation from CPB.

Plasma TNF-{alpha} and IL-6 concentrations were measured by means of capture enzyme-linked immunosorbent assay (Human TNF-{alpha} and IL-6 OptEIA; BD Pharmingen, San Diego, Calif). Cell-surface staining for TLR and CD14 was performed on whole blood according to published methods by using human monoclonal antibodies: anti-TLR-2 fluorescein isothiocyanate, anti-TLR-4 phycoerythrin (eBioscience, San Diego, Calif), and anti-CD14 peridinin chlorophyll protein (Becton Dickinson, San Diego, Calif).4 Eight thousand CD14+ cells were acquired for each sample; dead cells were gated out on a FACS Caliber flow cytometer (Becton Dickinson). TLR values were expressed as a ratio of the geometric mean fluorescence intensity to the matching isotype control for each sample.

Statistical analysis of changes over time used linear mixed models for longitudinal data fitted to log-transformed mean fluorescence intensity ratios (TLR values) and concentrations (IL-6 and TNF-{alpha}). Results are summarized by using geometric mean values with 95% confidence intervals (CIs). Analysis was performed with the Stata package (Stata Statistical Software, Release 8.1; StatCorp, College Station, Tex).

Results

CPB time was 109 minutes (95% CI, 91-186 minutes), and crossclamp duration was 66 minutes (95% CI, 60-110 minutes). Figure 1 shows individual toll and cytokine data for each patient, and Table 1 provides geometric mean values at each time point. There was a clear increase in values after bypass for TLR-2 (log scale linear trend, P = .008) and TLR-4 (P < .001), fitting a line constrained to pass through the origin (ratio = 1) at the pre-CPB point. There was also strong evidence of linear increase in (log) IL-6 value (P < .001) but no change in TNF-{alpha} value (P = .4). For TLR-4 and IL-6, there was further evidence for curvature in the pattern of change over time, reflecting a flattening out or possible reduction by 48 hours after bypass.



View larger version (33K):
[in this window]
[in a new window]
 
Figure 1. Individual toll and cytokine data are shown for each patient. CPB, Cardiopulmonary bypass; XC, crossclamp; TLR, toll-like receptor; TNF-{alpha}, tumor necrosis factor {alpha}; IL-6, interleukin 6.

 

View this table:
[in this window]
[in a new window]
 
TABLE 1. Geometric mean of MFI ratios (relative to control level at pre-CPB baseline) for (TLR-2 and TLR-4) and geometric mean of concentrations of IL-6 and TNF-{alpha} at each time point, with 95% confidence intervals in parentheses

 
Discussion

For the first time, we have examined TLR expression in young children undergoing operations for CHD. Our study has demonstrated increased activation of the innate immune response in children after CPB, with specific upregulation of TLR-2 and TLR-4. There was a corresponding increase in IL-6 levels, which is one of the cytokines that is produced by stimulation of the TLRs. TNF-{alpha} levels were unchanged, possibly reflecting factors including the effects of steroids, hemofiltration, and ultrafiltration or perhaps supporting the suggestion that this cytokine does not contribute to CPB-induced SIRS.

The innate immune system plays a pivotal role in initiating first-line host defense to infection. This is dependent on recognition by TLRs of nonspecific proteins on invading pathogens; one such ligand is the lipopolysaccharide component of gram-negative bacterial cell walls. TLR signaling stimulates host cytokine gene expression, thus propagating the inflammatory response and providing the molecular link between innate and adaptive immunity.5

It has been recently suggested that the innate immune system might play a similar role in initiating SIRS to noninfectious stimuli, and our findings concur with those of a previous investigation in adults undergoing coronary surgery.3 The nature of the ligands that stimulate increased TLR expression in the current setting is not fully understood. Possible candidates include heat shock proteins 60 and 70, so-called endogenous ligands that are released in response to ischemia, stress, and tissue necrosis.3 Further studies will address these issues in more detail.

Conclusion

SIRS in young children after CPB is associated with activation of the innate immune response. Future therapeutic strategies targeted at the innate immune response might be useful in preventing bypass-associated SIRS.

References

  1. Brix-Christensen V. The systemic inflammatory response after cardiac surgery with cardiopulmonary bypass in children. Acta Anaesthesiol Scand. 2001;45:671–679[Medline]
  2. Lien E, Means TK, Heine H, Yoshimura A, Kusumoto S, Fukase K, et al. Toll-like receptor 4 imparts ligand-specific recognition of bacterial lipopolysaccharide. J Clin Invest. 2000;105:497–504[Medline]
  3. Dybdahl B, Wahba A, Lien E, Flo TH, Waage A, Qureshi N, et al. Inflammatory response after open heart surgery: release of heat-shock protein 70 and signaling through toll-like receptor-4. Circulation. 2002;105:685–690[Abstract/Free Full Text]
  4. Riordan SM, Skinner N, Nagree A, McCallum H, McIver CJ, Kurtovic J, et al. Peripheral blood mononuclear cell expression of toll-like receptors and relation to cytokine levels in cirrhosis. Hepatology. 2003;37:1154–1164[Medline]
  5. Zhang G, Ghosh S. Toll-like receptor-mediated NF-kappaB activation: a phylogenetically conserved paradigm in innate immunity. J Clin Invest. 2001;107:13–19[Medline]



This article has been cited by other articles:


Home page
Am. J. Respir. Crit. Care Med.Home page
N. Pathan, M. Burmester, T. Adamovic, M. Berk, K. W. Ng, H. Betts, D. Macrae, S. Waddell, M. Paul-Clark, R. Nuamah, et al.
Intestinal Injury and Endotoxemia in Children Undergoing Surgery for Congenital Heart Disease
Am. J. Respir. Crit. Care Med., December 1, 2011; 184(11): 1261 - 1269.
[Abstract] [Full Text] [PDF]


Home page
J. Thorac. Cardiovasc. Surg.Home page
C. F. Stocker, L. S. Shekerdemian, S. B. Horton, K. J. Lee, R. Eyres, Y. D'Udekem, and C. P. Brizard
The influence of bypass temperature on the systemic inflammatory response and organ injury after pediatric open surgery: A randomized trial
J. Thorac. Cardiovasc. Surg., July 1, 2011; 142(1): 174 - 180.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
A. Linde, D. Mosier, F. Blecha, and T. Melgarejo
Innate immunity and inflammation - New frontiers in comparative cardiovascular pathology
Cardiovasc Res, January 1, 2007; 73(1): 26 - 36.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Author home page(s):
Christian P. Brizard
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Stocker, C. F.
Right arrow Articles by Penny, D. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Stocker, C. F.
Right arrow Articles by Penny, D. J.
Related Collections
Right arrow Molecular biology


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS